High proportion of men with prostate cancer die from the disease

NewsGuard 100/100 Score

Up to half the number of men with prostate cancer who die do so as a direct result of the disease, rather than from other causes according to a new study presented at the National Cancer Intelligence Network conference in London.

Researchers from King's College London looked at 50,066 men with prostate cancer in the Thames Cancer Registry between 1997 and 2007.

Of this group, 20,181 died during the 10 years. And, of these deaths, 49 per cent were recorded as being due to the cancer itself. According to the study twelve per cent of deaths were caused by other cancers, 17 per cent from heart disease, 8 per cent were from pneumonia and 13 per cent were due to other causes.

Prostate cancer is the second most common cause of cancer death in UK men, after lung cancer. Every year around 37,000 men are diagnosed and over 10,100 men die from the disease.Professor Henrik Moller, study author from King's College London and head of analysis and research at the NCIN, said: "Our data show that a high proportion of men with prostate cancer die from the cancer. Our findings challenge the commonly held view that most men with prostate cancer will die with the disease rather than from it."

Simon Chowdhury, study author and consultant oncologist at Guy's and St Thomas' NHS Foundation Trust, said: "This confirms that prostate cancer is a major cause of morbidity and mortality for a large number of men and the importance of ongoing and future research into this area."

Comments

  1. Gedson Evaristo de Santi Gedson Evaristo de Santi Brazil says:

    As stated in this interesting article: "Our findings challenge the commonly held view that most men with prostate cancer will die with the disease rather than from it" it is really news for us, but unfortunately bad news. Researches must go on that.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels